WO2018144093A3 - Formulations pour soins de la peau améliorés - Google Patents
Formulations pour soins de la peau améliorés Download PDFInfo
- Publication number
- WO2018144093A3 WO2018144093A3 PCT/US2017/059960 US2017059960W WO2018144093A3 WO 2018144093 A3 WO2018144093 A3 WO 2018144093A3 US 2017059960 W US2017059960 W US 2017059960W WO 2018144093 A3 WO2018144093 A3 WO 2018144093A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hyaluronic acid
- collagen
- formulations
- skin care
- improved skin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/001—Preparations for care of the lips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
La présente invention concerne des compositions et des procédés d'administration de collagène et/ou d'acide hyaluronique à un sujet humain. Les vésicules lipidiques contenant du collagène et/ou de l'acide hyaluronique de l'invention fournissent un système d'administration de protéine de collagène et/ou d'acide hyaluronique qui améliore significativement l'état de la peau d'un sujet humain tout en éliminant les problèmes associés à l'instabilité chimique et physique du collagène et/ou de l'acide hyaluronique ainsi que des réponses immunitaires associées.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662416987P | 2016-11-03 | 2016-11-03 | |
US62/416,987 | 2016-11-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2018144093A2 WO2018144093A2 (fr) | 2018-08-09 |
WO2018144093A3 true WO2018144093A3 (fr) | 2019-03-07 |
Family
ID=63040032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2017/059960 WO2018144093A2 (fr) | 2016-11-03 | 2017-11-03 | Formulations pour soins de la peau améliorés |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2018144093A2 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12011437B1 (en) | 2017-06-07 | 2024-06-18 | Arcutis Biotherapeutics, Inc. | Roflumilast formulations with an improved pharmacokinetic profile |
US20210161870A1 (en) | 2017-06-07 | 2021-06-03 | Arcutis Biotherapeutics, Inc. | Roflumilast formulations with an improved pharmacokinetic profile |
US11129818B2 (en) | 2017-06-07 | 2021-09-28 | Arcutis Biotherapeutics, Inc. | Topical roflumilast formulation having improved delivery and plasma half life |
US9895359B1 (en) | 2017-06-07 | 2018-02-20 | Arcutis, Inc. | Inhibition of crystal growth of roflumilast |
JP7317964B2 (ja) * | 2019-04-01 | 2023-07-31 | ジェルター, インコーポレイテッド | 組換えコラーゲンの局所製剤 |
US20200405621A1 (en) * | 2019-06-28 | 2020-12-31 | The Procter & Gamble Company | Skin Care Composition |
US11786451B2 (en) | 2019-06-28 | 2023-10-17 | The Procter & Gamble Company | Skin care composition |
GB2604239A (en) * | 2019-07-26 | 2022-08-31 | Pandorum Tech Private Limited | Bioengineered formulation, process for preparing and implementations thereof |
EP3968948A1 (fr) * | 2019-07-29 | 2022-03-23 | Giuliani S.p.A. | Composition cosmétique à charge combinée et effet régénérateur cutané |
CA3155131A1 (fr) | 2019-09-23 | 2021-04-01 | Dds Research Inc. | Compositions de vesicules lipidiques a l'aide d'agents ameliorant la penetration |
CN111036156A (zh) * | 2020-01-14 | 2020-04-21 | 江苏罗格斯生物科技有限公司 | 一种绿色功能因子精准控制材料的制备方法 |
CN111281840B (zh) * | 2020-02-13 | 2022-03-29 | 广州伊尔美生物科技有限公司 | 一种亮颜美肤霜及其制备方法 |
CA3153934C (fr) * | 2020-05-07 | 2023-01-31 | David W. Osborne | Traitement d'affections cutanees a l'aide de tensioactifs anioniques a temperature de krafft elevee |
CN111494233B (zh) * | 2020-06-02 | 2023-07-14 | 康珞生物科技(武汉)有限公司 | 一种胶原短肽脂质体的制备方法及应用 |
CN112057351B (zh) * | 2020-09-22 | 2023-01-24 | 西安诗莱梦特生物科技有限公司 | 透明质酸-羟丙基甲基纤维素复合水凝胶及其制备方法和应用 |
KR20230128261A (ko) * | 2020-09-30 | 2023-09-04 | 젤터, 인코포레이티드 | 콜라겐 또는 엘라스틴 폴리펩티드와 활성 성분의 조합을 포함하는 조성물 및 이의 사용 방법 |
CN114246818A (zh) * | 2021-03-08 | 2022-03-29 | 山东祥隆医药研究院有限公司 | 一种具有防敏、保湿、修复功效的精华乳及其制备方法 |
KR20240037871A (ko) * | 2021-03-24 | 2024-03-22 | 글로 파마, 인크. | 미용제 전달을 위한 멀티솜 지질 소포 |
CN117017869B (zh) * | 2023-09-15 | 2024-01-30 | 名宇(广东)化妆品科技有限公司 | 一种美白祛斑霜及制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5846561A (en) * | 1991-02-14 | 1998-12-08 | Baxter International Inc. | Method of binding collagen recognizing substances to liposomes |
US6992172B1 (en) * | 1999-11-12 | 2006-01-31 | Fibrogen, Inc. | Recombinant gelatins |
US20100221319A1 (en) * | 2005-10-03 | 2010-09-02 | Pinsky Mark A | Compositions and Methods for Improved Skin Care |
KR20110036664A (ko) * | 2009-10-02 | 2011-04-08 | 가부시키가이샤 페이스 | 콜라겐 수식 리포솜으로 이루어지는 화장료 기제 및 그것을 함유하는 피부 화장료 |
CN102988200A (zh) * | 2012-12-10 | 2013-03-27 | 北京莱米瑞克科技发展有限公司 | 脂质体养颜护肤品 |
-
2017
- 2017-11-03 WO PCT/US2017/059960 patent/WO2018144093A2/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5846561A (en) * | 1991-02-14 | 1998-12-08 | Baxter International Inc. | Method of binding collagen recognizing substances to liposomes |
US6992172B1 (en) * | 1999-11-12 | 2006-01-31 | Fibrogen, Inc. | Recombinant gelatins |
US20100221319A1 (en) * | 2005-10-03 | 2010-09-02 | Pinsky Mark A | Compositions and Methods for Improved Skin Care |
KR20110036664A (ko) * | 2009-10-02 | 2011-04-08 | 가부시키가이샤 페이스 | 콜라겐 수식 리포솜으로 이루어지는 화장료 기제 및 그것을 함유하는 피부 화장료 |
CN102988200A (zh) * | 2012-12-10 | 2013-03-27 | 北京莱米瑞克科技发展有限公司 | 脂质体养颜护肤品 |
Also Published As
Publication number | Publication date |
---|---|
WO2018144093A2 (fr) | 2018-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018144093A3 (fr) | Formulations pour soins de la peau améliorés | |
AU2018240515A1 (en) | Nucleic acids encoding CRISPR-associated proteins and uses thereof | |
MX2018004616A (es) | Cosmetica qie tiene bacterias probioticas. | |
MY188139A (en) | Sodium channel modulators for the treatment of pain | |
MX2020005247A (es) | Metodos y formulaciones que permiten la modulacion de respuestas inmunitarias relacionadas con la administracion de un farmaco biofarmaceutico. | |
IN2014CN04187A (fr) | ||
MX2022009155A (es) | Nuevos profarmacos polimericos de la hormona del crecimiento humana (hgh). | |
PH12014501693A1 (en) | Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof | |
MY181928A (en) | Sodium channel modulators for the treatment of pain and diabetes | |
CY1119957T1 (el) | Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος | |
CL2019001586A1 (es) | Insulina que contiene composiciones farmacéuticas. | |
MX364800B (es) | Tilmicosina de accion prolongada mejorada y el uso de la misma en el tratamiento del complejo respiratorio bovino (crb) y en el periodo de la vaca seca. | |
PH12018500036A1 (en) | Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid | |
MY191980A (en) | Formulations containing an extract of echinacea and linoleic acid derivatives | |
IN2014DN03213A (fr) | ||
EP4275746A3 (fr) | Vésicules extracellulaires issues de cellules de lignée ostéoblastique, à usage thérapeutique et diagnostique | |
MX2018008644A (es) | Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espir o-[4.5]-decano. | |
MX2018008645A (es) | Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano. | |
MX2016015211A (es) | Formulaciones topicas y usos de las mismas. | |
MX2018000262A (es) | Usos terapeuticos de formulaciones de berberina. | |
MX2016016400A (es) | Formulaciones de oximetazolina estabilizadas y sus usos. | |
BR112018071363A2 (pt) | composições farmacêuticas orais de nicotinamida | |
BR112014027653A2 (pt) | formulações para a liberação dos ingredientes ativos | |
MX2016005976A (es) | Formulaciones de tripeptido liofilizado estables en almacenamiento. | |
IN2014DN09240A (fr) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17895323 Country of ref document: EP Kind code of ref document: A2 |